Kyver­na shares safe­ty da­ta for CAR-T; Evotec gets $75M mile­stone

Plus, news about Bound­less Bio, Pelage, Ac­tu­ate Ther­a­peu­tics and Mer­sana Ther­a­peu­tics:

Kyver­na Ther­a­peu­tics touts ear­ly safe­ty of CAR-T ther­a­py: The biotech said the first 36 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER